Your browser doesn't support javascript.
loading
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS).
Jia, Weiping; Ma, Jianhua; Miao, Heng; Wang, Changjiang; Wang, Xiaoyue; Li, Quanmin; Lu, Weiping; Yang, Jialin; Zhang, Lihui; Yang, Jinkui; Wang, Guixia; Zhang, Xiuzhen; Zhang, Min; Sun, Li; Yu, Xuefeng; Du, Jianling; Shi, Bingyin; Xiao, Changqing; Zhu, Dalong; Liu, Hong; Zhong, Liyong; Xu, Chun; Xu, Qi; Liang, Ganxiong; Zhang, Ying; Li, Guangwei; Gu, Mingyu; Liu, Jun; Yuan, Guoyue; Yan, Zhaoli; Yan, Dewen; Ye, Shandong; Zhang, Fan; Ning, Zhiqiang; Cao, Haixiang; Pan, Desi; Yao, He; Lu, Xianping; Ji, Linong.
Afiliación
  • Jia W; Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai 200233, China. E
  • Ma J; Nanjing First Hospital, Nanjing 210029, China.
  • Miao H; The Second Hospital Affiliated to Nanjing Medical University, Nanjing 210011, China.
  • Wang C; The First Hospital Affiliated to Anhui Medical University, Hefei 230031, China.
  • Wang X; The First People's Hospital of Yueyang, Yueyang 414000, China.
  • Li Q; PLA Rocket Force Characteristic Medical Center, Beijing 100085, China.
  • Lu W; Huai'an First People's Hospital, Huai'an 223300, China.
  • Yang J; The Central Hospital of Minhang District of Shanghai, Shanghai 201100, China.
  • Zhang L; The Second Hospital of Heibei Medical University, Shijiazhuang 050000, China.
  • Yang J; Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China.
  • Wang G; The First Hospital of Jilin University, Changchun 130021, China.
  • Zhang X; Tongji Hospital of Tongji University, Shanghai 200092, China.
  • Zhang M; The Qingpu Branch of Zhongshan Hospital Affiliate to Fudan University, Shanghai 201700, China.
  • Sun L; Siping Central People's Hospital, Siping 136000, China.
  • Yu X; Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
  • Du J; The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
  • Shi B; The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Xiao C; The First Affiliated Hospital of Guangxi Medical University (The Western Hospital), Nanning 530021, China.
  • Zhu D; Gulou Hospital Affiliated to Nanjing Medical University, Nanjing 210008, China.
  • Liu H; The First Affiliated Hospital of Guangxi Medical University (The Eastern Hospital), Nanning 530021, China.
  • Zhong L; Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Xu C; The General Hospital of the Chinese People's Armed Police Forces, Beijing 100022, China.
  • Xu Q; The Second Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.
  • Liang G; Zhongshan People's Hospital, Zhongshan 528403, China.
  • Zhang Y; The Third Hospital Affiliated to Guangzhou Medical College, Guangzhou 510150, China.
  • Li G; Fuwai Hospital, Beijing 100037, China.
  • Gu M; Shanghai First People's Hospital, Shanghai 200080, China.
  • Liu J; Shanghai 5th People's Hospital, Shanghai 200040, China.
  • Yuan G; The Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China.
  • Yan Z; The Affiliated Hospital of Inner Mongolia, Hohhot 000306, China.
  • Yan D; Shenzhen Second People's Hospital, Shenzhen 518035, China.
  • Ye S; Anhui Provincial Hospital, Hefei 518035, China.
  • Zhang F; Beijing University Shenzhen Hospital, Shenzhen 518036, China.
  • Ning Z; Shenzhen Chipscreen Biosciences, Ltd., Shenzhen 518057, China.
  • Cao H; Shenzhen Chipscreen Biosciences, Ltd., Shenzhen 518057, China.
  • Pan D; Shenzhen Chipscreen Biosciences, Ltd., Shenzhen 518057, China.
  • Yao H; Shenzhen Chipscreen Biosciences, Ltd., Shenzhen 518057, China.
  • Lu X; Shenzhen Chipscreen Biosciences, Ltd., Shenzhen 518057, China.
  • Ji L; Peking University People's Hospital, Beijing 100044, China. Electronic address: jiln@bjmu.edu.cn.
Sci Bull (Beijing) ; 66(15): 1581-1590, 2021 08 15.
Article en En | MEDLINE | ID: mdl-36654287
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Fosfato de Sitagliptina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Sci Bull (Beijing) Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Fosfato de Sitagliptina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Sci Bull (Beijing) Año: 2021 Tipo del documento: Article